Long-acting bioengineered platelets with internal doxorubicin loaded and external quercetin liposomes anchored for post-surgical tumor therapy
Journal of Controlled Release · 2025
DOI: 10.1016/j.jconrel.2025.02.042 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Controlled Release, 2025. Verfasst von Qi Lu und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics, Wuya College of Innovation, Shenyang Pharmaceutical University, 103 Wenhua Road, Shenyang, Liaoning, 110016, PR China. Hauptthemen laut MEDLINE: Blood Platelets, Doxorubicin, Quercetin, Antibiotics, Antineoplastic. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: National Postdoctoral Program for Innovative Talents, National Key Research and Development Program of China, China Postdoctoral Science Foundation.
Abstract (Originalsprache)
Due to its natural tumor targeting ability, platelet-based drug delivery platform shows the great potential for tumor targeted treatment. However, both limited in vitro storage stability and rapid in vivo clearance rate severely restrict its clinical application. Here, utilizing the spatial structure of platelets precisely, chemotherapy drug doxorubicin (Dox) and liposomes-containing quercetin (Que) are loaded inside and anchored outside platelets, respectively, for establishing the engineered platelet platform (PDQLs). Dox plays the important role in inhibiting tumor growth, while Que mainly inhibits platelet apoptosis through activating serine/threonine protein kinase. PDQLs show the strong ability to resist external stimulation and physical damage. After being stored at room temperature for 4 days, more than 70 % of the platelets remain active. Given the natural wound tropism and tumor targeting abilities, the tumor accumulation of PDQLs is 1.02-fold higher than that of the solution. Base on the stealth characteristics of platelets and the continuous action of Que, PDQLs exhibit 10.63-fold increase area under the curve of solution. PDQLs can balance the anti-tumor recurrence and metastasis efficacy after surgery and safety. Our findings open a promising perspective and new sights for the development of bioengineered platelet platform in clinical application.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutics, Wuya College of Innovation, Shenyang Pharmaceutical University, 103 Wenhua Road, Shenyang, Liaoning, 110016, PR China.
- School of Pharmacy, Shenyang Pharmaceutical University, 103 Wenhua Road, Shenyang, Liaoning, 110016, PR China.
- Department of Pharmacy, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, China.
- School of Life Science and Biopharmaceutics, Shenyang Pharmaceutical University, 103 Wenhua Road, Shenyang, Liaoning, 110016, PR China.
- Department of Pharmaceutics, Wuya College of Innovation, Shenyang Pharmaceutical University, 103 Wenhua Road, Shenyang, Liaoning, 110016, PR China; Joint International Research Laboratory of Intelligent Drug Delivery Sy…
- Department of Pharmaceutics, Wuya College of Innovation, Shenyang Pharmaceutical University, 103 Wenhua Road, Shenyang, Liaoning, 110016, PR China. Electronic address: wangkaiyuan@hotmail.com.
Förderung
- National Postdoctoral Program for Innovative Talents
- National Key Research and Development Program of China
- China Postdoctoral Science Foundation
- Department of Education of Liaoning Province
- National Natural Science Foundation of China
- Heilongjiang Provincial Postdoctoral Science Foundation
- Liaoning Revitalization Talents Program
Zitieren
APA
Lu, Q., Han, Z., Wang, X., Du, L., Fan, X., Zhao, J., Zhu, R., Wang, H., Song, J., Shen, W., Zhang, H., He, Z., Wang, K., & Sun, J. (2025). Long-acting bioengineered platelets with internal doxorubicin loaded and external quercetin liposomes anchored for post-surgical tumor therapy. Journal of Controlled Release. https://doi.org/10.1016/j.jconrel.2025.02.042
Vancouver
Lu Q, Han Z, Wang X, Du L, Fan X, Zhao J, et al. Long-acting bioengineered platelets with internal doxorubicin loaded and external quercetin liposomes anchored for post-surgical tumor therapy. Journal of Controlled Release. 2025. doi:10.1016/j.jconrel.2025.02.042
BibTeX
@article{Lu2025,
author = {Lu, Qi and Han, Zeyu and Wang, Xia and Du, Lili and Fan, Xiaoyuan and Zhao, Jian and Zhu, Ruihong and Wang, Helin and Song, Jiaxuan and Shen, Wenwen and Zhang, Haotian and He, Zhonggui and Wang, Kaiyuan and Sun, Jin},
title = {Long-acting bioengineered platelets with internal doxorubicin loaded and external quercetin liposomes anchored for post-surgical tumor therapy},
journal = {Journal of Controlled Release},
year = {2025},
doi = {10.1016/j.jconrel.2025.02.042}
}
EUVIMED